Skip to main content
SpringerLink
Log in

Serum copper in malignant neoplasia with special reference to the cervix uteri

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

Serum copper levels (SCl) were determined in normal patients and in patients with primary tumors of different sites, measurements being made before and after therapy. The serum copper was elevated in the presence of all the different types of tumor examined. In patients not responding to treatment and those who relapsed, the serum copper remained constant or became higher. SCl may provide an effective means of evaluating the extent of the disease and is of value in the estimation of prognosis after therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albert L, Hienzsch E, Arndt J, Kriester A (1972) Bedeutung und Veränderungen des Serum-Kupferspiegels während und nach der Bestrahlung von Harnblasenkarzinomen. Z Urol 8:561–566

    Google Scholar 

  • Breiter DN, Diasia RB, Neifield JP, Rousch ML, Rosenberg SA (1978) Serum copper and zinc measurements in patients with osteogenic sarcoma. Cancer 42:598–602

    PubMed  Google Scholar 

  • Campbell CH, Brown R, Linder MC (1981) Circulating ceruloplasmin is an important source of copper for normal and malignant animal cells. Biochim Biophys Acta 678:27–31

    PubMed  Google Scholar 

  • Cecil Smit J, Brown ED (1976) Effects of oral contraceptive agents on trace element metabolism, a review. In: Prasad, Oberleas (eds) Trace elements in health and disease. II. Academic Press, New York, pp 315–345

    Google Scholar 

  • Garofolo JA, Ashikari H (1980) Serum zinc, copper and the Cu/Zn ratio in patients with benign and malignant breast lesions. Cancer 46:2683–2685

    Google Scholar 

  • Hrgovcic M, Tessmer CF, Brown BW, Wilbur JR, Mumford DM, Thomas FB, Schullenberger CF, Taylor G (1973) Serum copper studies in lymphomas and acute leukemias. Prog Clin Cancer 5:121–153

    PubMed  Google Scholar 

  • Koprivova H, Dienstbier Z, Samal M, Foltynova (1982) Ceruloplasmin in Hodgkin's disease. Neoplasma 29:333–340

    PubMed  Google Scholar 

  • Linder MC (1977) Iron and Copper metabolism in cancer as exemplified by changes in ferritin and ceruloplasmin in rats with transplantable tumors. Advances in Experimental Medicine and Biology 92:643–664

    PubMed  Google Scholar 

  • Linder MC (1978) In Morris hepatomas, mechanism of regulation (Morris HP, Criss WE eds) Plenum Press, New York, pp 643–664

    Google Scholar 

  • Linder MC, Moor JR (1978) In prevention and detection of cancer Part II, Detection, Vol. 1, pp 191 Plenum Press, New York

    Google Scholar 

  • Linder MC, Munro HN (1973) Iron and copper metabolism during development. Enzyme 15:11–138

    Google Scholar 

  • MacMillan KL, Wilson FD, Fisher GL, Grisp CE (1974) Status of cobalt 60 pilot study. In annual report University of Calif. Davis-CA, Radiobiology Laboratory UCD 472-121, 13–17

  • Mortazavi S, Bani Hashiemi A, Mazaferi M, Raffi A (1972) Values of serum copper measurements in lymphoma and several other malignancies. Cancer 29:1193–1198

    PubMed  Google Scholar 

  • O'Leary JA, Feldman M (1970) Serum copper alterations in genital cancer. Surg Forum 21:411–412

    PubMed  Google Scholar 

  • Petering DH (1978) In Inorganic and nutritional aspects of cancer (Schrauzer GN ed) pp 79. Plenum Press, New York

    Google Scholar 

  • Pizzoli G, Savarini T, Molino AM, Ambrosetti A, Todeschini G, Vettone L (1978) The diagnostic value of serum copper levels and haematochemical parameters in malignancies. Tumori 64:55–61

    PubMed  Google Scholar 

  • Schwartz MK (1975) Role of trace elements in cancer. Cancer Res 35:3481–3487

    PubMed  Google Scholar 

  • Siscley B, Capacho-Delgado L, Cavella RJ, Newall J (1970) The level of serum copper as an indication of activity, prognosis and response to therapy in Hodgkin's disease. Tenth International Cancer Congress, Texas, pp 789

  • Tessmer CF, Hrgovcic M, Thomas PB, Wilbur J (1972) Longterm serum copper studies in acute leukemia in children. Cancer 30:358–365

    PubMed  Google Scholar 

  • Thorling EB, Thorling K (1976) The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963–1973. Cancer 38:225–231

    PubMed  Google Scholar 

  • Varley H (ed) (1975) Practical clinical biochemistry. Heinemann, London, pp 477–478

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Tumor Biology, Chittaranjan National Cancer Research Centre, 37, S. P. Mookerjee Road, 700 026, Calcutta, India

    Prabir Kishore Chakravarty & J. Roy Chowdhury

Authors
  1. Prabir Kishore Chakravarty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Roy Chowdhury
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chakravarty, P.K., Chowdhury, J.R. Serum copper in malignant neoplasia with special reference to the cervix uteri. J Cancer Res Clin Oncol 108, 312–315 (1984). https://doi.org/10.1007/BF00390464

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00390464

Key words

Search

Navigation